National Health Investors Inc (NYSE:NHI) – KeyCorp reduced their FY2019 earnings per share estimates for National Health Investors in a note issued to investors on Sunday, December 2nd. KeyCorp analyst J. Sadler now expects that the real estate investment trust will earn $5.50 per share for the year, down from their previous estimate of $5.62.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, November 6th. The real estate investment trust reported $0.97 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.39 by ($0.42). National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. The firm had revenue of $74.92 million for the quarter, compared to the consensus estimate of $73.72 million. During the same period in the prior year, the business earned $1.37 EPS. The company’s quarterly revenue was up 5.0% compared to the same quarter last year.

Other equities research analysts also recently issued reports about the company. Zacks Investment Research downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Friday, November 9th. Cantor Fitzgerald reissued a “hold” rating and issued a $80.00 price objective on shares of National Health Investors in a research note on Thursday, November 8th. Finally, Wells Fargo & Co reaffirmed a “hold” rating on shares of National Health Investors in a report on Tuesday, August 28th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $75.22.

Shares of NYSE NHI opened at $80.15 on Wednesday. National Health Investors has a one year low of $62.71 and a one year high of $81.60. The stock has a market cap of $3.28 billion, a price-to-earnings ratio of 15.04, a price-to-earnings-growth ratio of 3.65 and a beta of 0.34. The company has a debt-to-equity ratio of 0.89, a current ratio of 14.53 and a quick ratio of 14.53.

A number of large investors have recently added to or reduced their stakes in NHI. Truvestments Capital LLC acquired a new stake in National Health Investors during the third quarter worth approximately $108,000. First Hawaiian Bank acquired a new stake in shares of National Health Investors during the 3rd quarter valued at $162,000. Nissay Asset Management Corp Japan ADV bought a new position in National Health Investors during the 3rd quarter worth $203,000. MML Investors Services LLC bought a new position in National Health Investors during the 3rd quarter worth $212,000. Finally, Woodmont Investment Counsel LLC bought a new position in National Health Investors during the 2nd quarter worth $211,000. Hedge funds and other institutional investors own 69.36% of the company’s stock.

In related news, Director Robert A. Mccabe, Jr. sold 1,250 shares of the company’s stock in a transaction dated Monday, November 26th. The stock was sold at an average price of $75.41, for a total transaction of $94,262.50. Following the sale, the director now owns 13,120 shares in the company, valued at $989,379.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 5.19% of the stock is owned by corporate insiders.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: Growth Stocks

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.